Zusammenfassung
Schon Hippokrates beobachtete etwa im Jahr 400 v. Chr. ein Fieber, das verursacht wird durch eine Materie, die fault. Eine „Fäulnis des Blutes“, die ein kontinuierliches Fieber bedingt, wurde von Ibn Sina (Avicenna) um 1000 n. Chr. beschrieben.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anker S, Egerer KR, Volk H-D, Kox WJ, Poole-Wilson PA, Coats AJS (1997) Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79: 1426 - 1430
Baue AE (1975) Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg 110: 779 - 781
Bone RC (1996) Sir Isaak Newton, sepsis, SIRS, and CARS. Crit Care Med 24: 1125 - 1128
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz GA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 653 - 658
Brun-Buisson C, for the French ICU Group for Severe Sepsis (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 274: 968 - 974
Buller HR, Bolwerk C, Cate JT, Roos J, Kahle LH, Cate JWT (1982) Postoperative hemostatic profile in relation to gram-negative septicemia. Crit Care Med 10: 311 - 315
Burtin P, Bollaert PE, Feldmann L et al. (1994) Prognosis of stroke patients undergoing mechanical ventilation. Intensive Care Med 20: 32 - 36
Campion EW, Mulley AG, Goldstein R,Barnett GO, Thibault GE (1981) Medical intensive care for the elderly. JAMA 246: 2052 - 2056
Centers for Disease Control (1990) Increase in National Hospital Discharge Survey rates for septicaemia - United States, 1979-1987. Morb Mortal Wkly Rep 39: 31 - 34
Deventer SJH van, Buller HR, TenCate JW, Sturk A (1988) Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet I: 605 - 608
Dragsted L, Qvistt J, Madsen M (1989) Outcome from intensive care. II. A 5-year study of 1308 patients: shortterm outcome. Europ J Anaesth 6: 131 - 144
Fein AM, Bernard GR, Criner GJ, Fletcher EC, Good JT Jr, Knaus WA, Levy H, Matuschak GM, Shanies HM, Taylor RW, Rodell TC, for the CP-0127 SIRS and Sepsis Study group (1997) Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). JAMA 277: 482 - 487
French Multicenter Group of ICU Research (1989) Factors related to outcome in intensive care. French multicenter study. Crit Care Med 17: 305 - 308
Fulop M, Adel HN, Webster A, Levin G (1989) Comparison of the reactions of older and younger patients to intensive care. Grit Care Med 17: 1223 - 1227
Gawaz M, Fateh-Moghadam S, Pilz G, Gurland H-J,Werdan K (1995) Severity of multiple organ failure but not of sepsis correlates with irreversible platelet degranulation. Infection 23: 16 - 23
Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators. A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107-1116
Grundmann R, Ingenhoff E (1986) Postoperative Bestimmung des Endotoxinverlaufs. Dtsch Med Wochenschr 111: 457 - 462
Harris RL, Musher DM, Bloom K et al. (1987) Manifestations of sepsis. Arch Int Med 147: 1895 - 1906
Höring FO, Pohle HD (1991) Sepsis. Urban & Schwarzenberg, München Wien Baltimore ( Klinik der Gegenwart, Bd I, E 115 )
Kieft H, Hoepelman AI, Zhou W, Rozenberg-Arska M, Struyvenberg A, Verhoef J (1993) The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Int Med 153: 2241-2247
Knaus W, Draper E, Wagner D, Zimmerman 1 (1985) Prognosis in acute organ system failure. Ann Surg 202: 685 - 693
Knaus WA, Wagner DP, Draper EA et al. (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1000: 1619 - 1639
Kreymann G, Wolf M (1996) Geschichte and Definition der Sepsis - Brauchen wir eine Terminologie? Anaesthesiol Intensivmed Notfallmed Schmerzther 31: 9 - 14
Le Gall JR, Lemeshow S, Leleu G, Klar J, Huillard J, Rue M, Teres D,Artigas A (1995) Customized probability models for early severe sepsis in adult intensive care patients. Intensive Care Unit Scoring Group. JAMA 273: 644-50
Le Gall JR, Lemeshov S, Saulnier F (1993) A new simplified acute physiology score ( SAPS II) based on a European/North American multicenter study. JAMA 270: 2957-2963
Lindner A, Zierz S (1998) Auswirkungen der Sepsis auf das Nervensystem: Pathophysiologie, Klinik, Prophylaxe and Therapie der Critical Illness-Enzephalopathie, -Neuropathie and -Myopathie. Internist 39: 493-501
Lode H (1983) Therapie der Sepsis. Arzneimitteltherapie 1: 82 - 89
Martin MA (1991) The respiratory distress syndrome in adults with gram-negative sepsis. In: Vincent JL (ed) Update in intensive care and emergency medicine, 14. Springer, Berlin Heidelberg New York Tokio, S. 182 - 191
Members of the American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864 - 874
Muckart DJ, Bhagwanjee S (1997) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 25: 1789 - 1795
Müller-Werdan U, Kuhn C, Heinroth K, Prondzinsky R, Loppnow H, Schumann H, Darmer D, Holtz J, Werdan K (1997) Die akute septische Kardiomyopathie. Intensivmed 34: 333 - 351
Niskanen M, Kari A, Halonen P, the Finnish ICU Study Group (1996) Five-year survival after intensive care - comparison of 12.180 patients with the general population. Crit Care Med 24: 1962 - 1967
Oettinger W, Berger D, Beger HG (1987) The clinical significance of prostaglandine and thromboxane as mediators of septic shock. Klin Wochenschr 63: 821 - 826
Opal SM, Fisher CJ, Dhainaut J-FA et al., the Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25: 1115 - 1124
Parrillo JE, Parker MM, Natanson C et al. (1990) Septic shock in humans - advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy.Ann Intern Med 113: 227 - 240
Pilz G, Fateh-Moghadam S, Viell B et al. (1993) Supplemental immunoglobulin therapy in sepsis and septic shock - comparison of mortality under treatment with polyvalent i.v. immunoglobulin vs. placebo. Theor Surg 8: 61 - 83
Pilz G, Werdan K (1998) Scores für Multiorgandysfunktion und Multiorganversagen. Internist 39: 502 - 508
Pittet D, Rangel-Frausto S, Li N et al. (1995) Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 21: 302 - 309
Reinhart K, Wiegand-Löhnert C,Grimminger F et al.,the MAK 195F Sepsis Study Group (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 24: 733-742
Sands KE, Bates DW, Lanken PN et al. (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 278: 234-240
Schölmerich (1998) Schockpankreas. Internist 39: 453 - 458
Schottmüller H (1914) Wesen und Behandlung der Sepsis. Verh Dtsch Ges Inn Med 31: 257
Schuster H-P (1991) Intensivtherapie im Alter. Med Klinik 86: 473 - 481
Schuster H-P (1998) Outcome nach Intensivtherapie. Med Klinik 93: 91 - 98
Schwartz S, Richardson J, Glasziou PP (1993) Quality-adjusted life years: originals, measurements, applications, objections. Aust J Publ Health 17: 272 - 278
Seige M, Werdan K (1998) Allgemeine Intensivtherapie. In: Paumgartner G, Riecker G (Hrsg) Therapie Innerer Krankheiten. Springer, Heidelberg New York Tokio (im Druck)
Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317: 659 - 665
Werdan K, Müller-Werdan U (1996) Schock, Kollaps und akute Kreislaufinsuffizienz. In: Erdmann E, Riecker G (Hrsg) Klinische Kardiologie. Springer, Berlin Heidelberg New York Tokio, S. 697 - 710
Werdan K (1998) Sinnvoller Einsatz von High-Tech-Medizin. MMW 140: 225 - 231
Winchell RJ, Hoyt DB (1996) Spectral analysis of heart rate variability in the ICU. J Surg Res 63: 11 - 16
Witthaut R, Werdan K (1996) Ergebnisforschung am Beispiel der Sepsis. Internist 37: 1249 - 1259
Witthaut R, Werdan K, Schuster H-P (1998) Multiorgandysfunktions-Syndrom und Multiorganversagen - Diagnose, Prognose und Therapiekonzepte. Internist 39: 493-501
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schuster, HP., Müller-Werdan, U. (2000). Definition und Diagnose von Sepsis und Multiorganversagen. In: Schuster, HP., Werdan, K. (eds) Intensivtherapie bei Sepsis und Multiorganversagen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07962-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-07962-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07963-8
Online ISBN: 978-3-662-07962-1
eBook Packages: Springer Book Archive